|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
JP2518911B2
(ja)
|
1987-10-23 |
1996-07-31 |
森永乳業株式会社 |
ｃ―ｆｍｓ癌原遺伝子の過剰発現によって特徴づけられた癌の処置用組成物および方法
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US6713610B1
(en)
|
1990-01-12 |
2004-03-30 |
Raju Kucherlapati |
Human antibodies derived from immunized xenomice
|
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US6300129B1
(en)
|
1990-08-29 |
2001-10-09 |
Genpharm International |
Transgenic non-human animals for producing heterologous antibodies
|
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
|
US5874299A
(en)
|
1990-08-29 |
1999-02-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5877397A
(en)
|
1990-08-29 |
1999-03-02 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
EP0955365A3
(en)
|
1992-06-09 |
2000-12-20 |
Chiron Corporation |
Crystallization of M-CSF
|
|
US20020193575A1
(en)
|
1993-09-07 |
2002-12-19 |
Smithkline Beecham P.L.C. |
Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
|
|
JPH10218791A
(ja)
|
1997-01-31 |
1998-08-18 |
Toagosei Co Ltd |
慢性関節リウマチ治療薬
|
|
US6972323B1
(en)
|
1997-04-01 |
2005-12-06 |
Sankyo Company, Limited |
Anti-Fas antibodies
|
|
US6342220B1
(en)
|
1997-08-25 |
2002-01-29 |
Genentech, Inc. |
Agonist antibodies
|
|
WO1999029345A1
(en)
|
1997-12-05 |
1999-06-17 |
La Jolla Institute For Experimental Medicine |
Inhibition of tumor growth by macrophage intervention
|
|
AU6366999A
(en)
|
1998-10-30 |
2000-05-22 |
Takeda Chemical Industries Ltd. |
Betacellulin protein-containing preparations
|
|
DE60024436T2
(de)
|
1999-05-07 |
2006-08-17 |
Genentech, Inc., South San Francisco |
Behandlung von autoimmunkrankheiten mit antagonisten die oberflächenmarker von b zellen binden
|
|
DE50002293D1
(de)
|
1999-10-28 |
2003-06-26 |
Hofbauer Reinhold |
Verwendung von csf-1-inhibitoren
|
|
WO2001034177A2
(en)
|
1999-11-08 |
2001-05-17 |
The Government Of The United States Of America, A S Represented By The Secretary, Department Of Hea Lth & Human Services, The National Institutes Of Health |
Method of treating a viral infection using antagonists of macrophage colony stimulating factor
|
|
US7108852B2
(en)
|
2000-03-20 |
2006-09-19 |
Warner-Lambert Company Llc |
Methods of treating inflammation using antibodies to M-CSF
|
|
US7455836B2
(en)
|
2000-05-08 |
2008-11-25 |
The University Of Melbourne |
Method of treatment and agents useful for same
|
|
US6773895B2
(en)
|
2000-09-01 |
2004-08-10 |
Boehringer Ingelheim Pharma Kg |
Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
|
|
US7247618B2
(en)
|
2001-04-30 |
2007-07-24 |
Tripathi Rajavashisth |
Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling
|
|
ATE440869T1
(de)
|
2001-06-20 |
2009-09-15 |
Fibron Ltd |
Fgfr3 blockierende antikírper, verfahren zum screening darauf und verwendungen davon
|
|
JP4727992B2
(ja)
|
2002-11-15 |
2011-07-20 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
癌転移および癌転移に伴なう骨量減少を予防および処置するための方法
|
|
AR045563A1
(es)
|
2003-09-10 |
2005-11-02 |
Warner Lambert Co |
Anticuerpos dirigidos a m-csf
|
|
PT1678314E
(pt)
|
2003-10-22 |
2012-11-27 |
Keck Graduate Inst |
Métodos de síntese de polipéptidos heteromultiméricos em levedura utilizando uma estratégia de conjugação haplóide
|
|
GB0325836D0
(en)
|
2003-11-05 |
2003-12-10 |
Celltech R&D Ltd |
Biological products
|
|
JP2007524671A
(ja)
|
2004-01-21 |
2007-08-30 |
カイロン コーポレイション |
Ｍ−ｃｓｆムテインおよびその使用
|
|
WO2005113596A2
(en)
|
2004-05-14 |
2005-12-01 |
Receptor Biologix, Inc. |
Cell surface receptor isoforms and methods of identifying and using the same
|
|
EP2287310B1
(en)
|
2004-07-22 |
2015-05-06 |
Five Prime Therapeutics, Inc. |
Compositions and methods using MGD-CSF in disease treatment
|
|
WO2006076288A2
(en)
|
2005-01-11 |
2006-07-20 |
Five Prime Therapeutics, Inc. |
Dna constructs for long-term expression of intravascularly injected naked dna
|
|
DE602006011574D1
(de)
|
2005-01-27 |
2010-02-25 |
Five Prime Therapeutics Inc |
Leitsequenzen zur anleitung von polypeptidsekretion und verfahren zur herstellung
|
|
US8003108B2
(en)
|
2005-05-03 |
2011-08-23 |
Amgen Inc. |
Sclerostin epitopes
|
|
JP2009515521A
(ja)
|
2005-11-10 |
2009-04-16 |
レセプター バイオロジックス， インコーポレイテッド |
レセプターアイソフォームおよびリガンドアイソフォームの産生のための方法
|
|
WO2007075933A2
(en)
|
2005-12-21 |
2007-07-05 |
Cell Signaling Technology, Inc. |
Translocation and mutant csf1r kinase in human leukemia
|
|
KR101358600B1
(ko)
|
2005-12-22 |
2014-02-06 |
조마 테크놀로지 리미티드 |
가용성 인간 ｍ-ｃｓｆ 수용체 및 이의 용도
|
|
RU2470665C2
(ru)
|
2006-01-05 |
2012-12-27 |
Новартис Аг |
Способы профилактики и лечения ракового метастаза и разрежения кости, связанного с раковым метастазом
|
|
AU2007248493B2
(en)
|
2006-05-04 |
2010-09-30 |
The Rockefeller University |
HCV coreceptor and methods of use thereof
|
|
US7833789B2
(en)
|
2006-08-01 |
2010-11-16 |
Fondazione Centro San Raffaele Del Monte Tabor |
Monocyte cell
|
|
WO2008060610A2
(en)
|
2006-11-17 |
2008-05-22 |
Biogen Idec Ma Inc. |
Systemic administration of colony stimulating factors to treat amyloid associated disorders
|
|
ATE494306T1
(de)
|
2007-02-14 |
2011-01-15 |
Vaccinex Inc |
Humanisierte anti-cd100-antikörper
|
|
WO2008124858A2
(en)
|
2007-04-11 |
2008-10-23 |
F-Star Biotechnologische Forschungs- Und Entwicklungsges. M.B.H. |
Targeted receptor
|
|
WO2008150383A1
(en)
|
2007-05-30 |
2008-12-11 |
Albert Einstein College Of Medicine Of Yeshiva University |
Csf-1r mutants
|
|
PT2188313T
(pt)
|
2007-08-21 |
2017-12-12 |
Amgen Inc |
Proteínas de ligação ao antigénio c-fms humano
|
|
US7981415B2
(en)
|
2007-09-07 |
2011-07-19 |
Cisthera, Inc. |
Humanized PAI-1 antibodies
|
|
US20090148883A1
(en)
|
2007-10-31 |
2009-06-11 |
Manthey Carl L |
Biomarker for assessing response to fms treatment
|
|
EP2241333A1
(en)
|
2007-12-12 |
2010-10-20 |
National Cancer Center |
Therapeutic agent for mll leukemia and moz leukemia of which molecular target is m-csf receptor, and use thereof
|
|
US8470977B2
(en)
|
2008-03-14 |
2013-06-25 |
Transgene S.A. |
Antibody against the CSF-1R
|
|
EP2262836B1
(en)
|
2008-03-14 |
2016-03-09 |
Transgene SA |
Antibody against the csf-1 r
|
|
WO2010062401A2
(en)
|
2008-11-26 |
2010-06-03 |
Five Prime Therapeutics, Inc. |
Treatment of osteolytic disorders and cancer using csf1r extracellular domain fusion molecules
|
|
US8080246B2
(en)
|
2008-11-26 |
2011-12-20 |
Five Prime Therapeutics, Inc. |
Colony stimulating factor 1 receptor (CSF1R) extracellular domain fusion molecules
|
|
KR101434070B1
(ko)
|
2009-12-10 |
2014-08-25 |
에프. 호프만-라 로슈 아게 |
인간 ｃｓｆ-1ｒ 세포외 도메인 4에 우선적으로 결합하는 항체 및 그의 용도
|
|
KR101647871B1
(ko)
|
2010-03-05 |
2016-08-11 |
에프. 호프만-라 로슈 아게 |
인간 ｃｓｆ-1ｒ에 대한 항체 및 이의 용도
|
|
WO2011107553A1
(en)
|
2010-03-05 |
2011-09-09 |
F. Hoffmann-La Roche Ag |
Antibodies against human csf-1r and uses thereof
|
|
AR080698A1
(es)
|
2010-04-01 |
2012-05-02 |
Imclone Llc |
Anticuerpo o fragmento del mismo que especificamente enlaza la variante de csf -1r humano, composicion farmaceutica que lo comprende, su uso para la manufactura de un medicamento util para el tratamiento de cancer y metodo para determinar si un sujeto es candidato para tratamiento de cancer basado e
|
|
EP3357510B1
(en)
*
|
2010-05-04 |
2020-08-05 |
Five Prime Therapeutics, Inc. |
Antibodies that bind csf1r
|
|
TW201307845A
(zh)
|
2010-12-13 |
2013-02-16 |
Novartis Ag |
預測方法及利用ｉｌ－１７拮抗劑治療關節炎的方法
|
|
EP2768861A1
(en)
|
2011-10-21 |
2014-08-27 |
Institut National de la Sante et de la Recherche Medicale (INSERM) |
A m-dc8+ monocyte depleting agent for the prevention or the treatment of a condition associated with a chronic hyperactivation of the immune system
|
|
SG11201401639QA
(en)
|
2011-10-21 |
2014-05-29 |
Transgene Sa |
Modulation of macrophage activation
|
|
CA2871445C
(en)
*
|
2012-05-11 |
2020-07-07 |
Five Prime Therapeutics, Inc. |
Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)
|
|
HK1212214A1
(en)
|
2012-08-31 |
2016-06-10 |
戊瑞治疗有限公司 |
Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)
|
|
CN107567336B
(zh)
*
|
2014-10-29 |
2021-12-31 |
戊瑞治疗有限公司 |
癌症的联合治疗
|